Abstract
The incidence of bladder cancer has increased in the last few decades, thus novel markers for early diagnosis and more efficacious treatment are urgently needed. It found that METTTL13 protein is aberrant expression in variety of human cancers and METTL13 was involved in oncogenic pathways. However, the role of METTL13 has been unexplored in bladder cancer to date. Here, expression of METTL13 was lower in bladder cancer tissue samples and cancer cell lines than in normal bladder tissue and cell lines. METTL13 was downregulated in the late stages of the disease and was maintained at low level throughout the tumor progression process based on tumor node metastasis (TNM) staging. Further research suggested that METTL13 negatively regulates cell proliferation in bladder cancer and reinstates G1/S checkpoint via the coordinated downregulation of CDK6, CDK4 and CCND1, decreased phosphorylation of Rb and subsequent delayed cell cycle progression. Moreover, METTL13-dependent inhibition of bladder cancer cell migration and invasion is mediated by downregulation of FAK (Focal adhesion kinase) phosphorylation, AKT (v-akt murine thymoma viral oncogene) phosphorylation, β-catenin expression and MMP-9 expression. These integrated efforts hav...Continue Reading
References
Apr 19, 1990·The New England Journal of Medicine·D RaghavanJ P Richie
Feb 27, 1999·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·T NagaseO Ohara
Dec 2, 1999·Nature Genetics·V E VelculescuK W Kinzler
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Jul 24, 2003·The Surgical Clinics of North America·S Eva SingletaryFrederick L Greene
Jan 31, 2004·PharmacoEconomics·Marc F BottemanRobert Hauser
Jan 22, 2005·Seminars in Radiation Oncology·Michael S Cookson
Oct 16, 2010·Cell·Jonghwan KimStuart H Orkin
Feb 23, 2012·Scientific Reports·Atsushi TakahashiKenzaburo Tani
Aug 30, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marialucia GalloriniViviana di Giacomo
Mar 14, 2013·The Journal of Clinical Endocrinology and Metabolism·Hsiu-Mei ChenShaw-Jenq Tsai
Sep 21, 2013·Life Sciences·Juan QinRong Deng
Sep 21, 2013·Cell Communication & Adhesion·Sekhar PalAmitava Chatterjee
May 7, 2014·Cell Cycle·Xiaomin LouD Joshua Liao
Jun 13, 2014·Investigational New Drugs·Lawrence M GelbertAlfonso de Dios
Sep 16, 2014·Marine Drugs·Jen-Jie LinYu-Jen Wu
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela DeMichelePeter O'Dwyer
Citations
Sep 1, 2016·Scientific Reports·Wen-Bo WuHai-Tao Liu
Mar 25, 2018·Human Mutation·Elena E KorbolinaTatyana I Merkulova
Sep 24, 2016·Journal of Translational Medicine·Yan LiAtsushi Takahashi
May 19, 2018·Nature Reviews. Drug Discovery·P Ann Boriack-SjodinRobert A Copeland
Apr 5, 2018·GigaScience·Shuai JiangJian Ren
Dec 27, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chirag NepalJesper B Andersen
Sep 5, 2018·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Yan LiAtsushi Takahashi
Nov 28, 2018·Chembiochem : a European Journal of Chemical Biology·Rong Huang
Apr 27, 2019·DNA and Cell Biology·Lu XingDongdong Tong
Jan 23, 2020·Cell Proliferation·Xichun CuiRanran Sun
Feb 20, 2019·Cell Death and Differentiation·Lei LiXin-Yuan Guan
May 15, 2021·Journal of Translational Medicine·Zhuonan LiuChuize Kong
Jul 23, 2021·Insect Molecular Biology·L BatagliaF M F Nunes